Tag Archives: Mohana Ray

Bayer to use Mammoth’s CRISPR systems for the development of vivo gene-editing therapies

Posted on 10, January 2022 by EuropaWire PR Editors

Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the full potential of novel CRISPR systems / Mammoth to receive upfront payment of USD 40 million, and potential future milestone payments of more … Read the full press release →

Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology

Tagged Bayer AG, Cas enzymes, Cas14, Casɸ, cell therapy, CRISPR, Dr. Imke Meyer, Dr. Peter Nell, gene augmentation, gene editing, gene therapy, gene-editing technology, gene-editing therapies, iPSC, liver diseases, Mammoth Biosciences, Mohana Ray, pluripotent stem cell, Stefan Oelrich, vivo projects